Arthritis & Rheumatism

PPI use ups risk of osteoporosis, osteopenia in femur

(HealthDay)—Proton pump inhibitor (PPI) use is associated with increased risk of developing osteoporosis and osteopenia in femur bones, according to a study published online May 31 in the International Journal of Rheumatic ...

Diseases, Conditions, Syndromes

Nano-enabled nasal spray for osteoporosis

The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a £545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of ...

Diseases, Conditions, Syndromes

New FRAX App launched by the International Osteoporosis Foundation

Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...

Medications

Common osteoporosis drug slows formation of new bone

Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society's Journal ...

page 18 from 38